Rare Disease Patient Engagement (RDPE) Guidance & Checklist

A practical tool to help rare disease value researchers and partners plan, document, and improve meaningful patient and caregiver engagement across the research lifecycle.

Decisions about rare disease treatments are often made with limited data and outcome measures that do not fully reflect what matters most to people living with these conditions. The Rare Disease Patient Engagement (RDPE) Guidance & Checklist was created to help close this gap by making it easier for patient partners, value researchers, and decision makers to work together from the start. This resource offers clear, step-by-step questions and examples to support early and ongoing patient engagement in comparative clinical effectiveness research (CER) and health technology assessment (HTA) for rare diseases.

For questions or feedback about the RDPE Guidance & Checklist in real projects, please contact Michelle Cheng, Research Lead, at michelle.cheng@valueresearch.org.

Our new RDPE Checklist video explores how researchers can better incorporate patient and caregiver perspectives throughout rare disease value research and assessment.

Start with these Core Resources

These materials are designed to work together. Begin  with the executive summary for a high-level overview, then use the full guidance document and printable checklist in your day-to-day work.

RDPE Guidance & Checklist

A detailed guide and checklist for planning, carrying out, and documenting patient and caregiver engagement. Includes relevant examples, key definitions, and HTA-relevant prompts.

Printable Structured Checklist

A standalone RDPE checklist table with key questions and response options organized by phase. Designed for use in team meetings, protocol reviews, and project check-ins.

Executive Summary

A brief overview of why this resource was developed, how it was created with multi-stakeholder input, and how it can support more patient-centered rare disease value research and HTA.